Showing results (1561-1570 of 2,364) with videos related to
Sort By:
Pageof 237
American Heart Journal Plus : Cardiology Research and Practice|March 24, 2025
Clinical practice patterns among older multimorbid adults presenting with suspected ischemic symptoms: A multi-center surveyStephanie Jou, Laura P Gelfman, Karen P Alexander, et al.JACC. Cardiovascular Imaging|January 19, 2013
Dynamic nature of nonculprit coronary artery lesion morphology in STEMI: a serial IVUS analysis from the HORIZONS-AMI trialZhijing Zhao, Bernhard Witzenbichler, Gary S Mintz, et al.Parasite Immunology|March 12, 2013
Influence of infection on malaria-specific antibody dynamics in a cohort exposed to intense malaria transmission in northern UgandaC Proietti, F Verra, M T Bretscher, et al.American Heart Journal|December 22, 2005
Impact of body mass index on outcomes after primary angioplasty in acute myocardial infarctionEugenia Nikolsky, Gregg W Stone, Cindy L Grines, et al.Journal of the American College of Cardiology|March 25, 2000
Percutaneous revascularization of the internal mammary artery graft: short- and long-term outcomesL Gruberg, G Dangas, R Mehran, et al.JACC. Cardiovascular Interventions|December 22, 2018
Outcomes Among Diabetic Patients Undergoing Percutaneous Coronary Intervention With Contemporary Drug-Eluting Stents: Analysis From the BIONICS Randomized TrialMaayan Konigstein, Ori Ben-Yehuda, Pieter C Smits, et al.JACC. Cardiovascular Interventions|March 22, 2014
Impact of nonculprit vessel myocardial perfusion on outcomes of patients undergoing percutaneous coronary intervention for acute coronary syndromes: analysis from the ACUITY trial (Acute Catheterization and Urgent Intervention Triage Strategy)Alexandra J Lansky, Vivian G Ng, Stephanie Meller, et al.JACC. Cardiovascular Interventions|January 21, 2017
First-in-Human Evaluation of a Novel Polymer-Free Drug-Filled Stent: Angiographic, IVUS, OCT, and Clinical Outcomes From the RevElution StudyStephen G Worthley, Alexandre Abizaid, Ajay J Kirtane, et al.The American Journal of Cardiology|July 16, 2003
Effect of abciximab versus tirofiban on activated clotting time during percutaneous intervention and its relation to clinical outcomes--observations from the TARGET trialIvan P Casserly, Eric J Topol, Gang Jia, et al.JAMA|November 6, 2003
Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trialGregg W Stone, Peter A McCullough, James A Tumlin, et al.Pageof 237